Abstract
Background Cardiac-fatty acid binding-protein(C-FABP) is a potential marker for the early diagnosis of acute myocardial infarction (AMI), and is one of the abundant proteins in heart.It is not totally Heart bound and is also found in liver, skeletal muscle, kidney and brain.Over or under calculation of the levels of C-FABP is because of its simultaneous coexpression with hepatic-FABP and solely cardiac-FABP in brain. Due to the rising incidence of chronic liver diseases CLD among cardiac patients,serum markers may crossover and create confusions while making the diagnosis, so the aim of this study was to demarcate the behaviour of fundamental serum markers of both diseases , specially when the two diseases coexists simultaneously. Method
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
